Hidden toll of ovarian cancer: new study reveals patient and caregiver struggles
NCT ID NCT07035067
First seen Jan 04, 2026 · Last updated Jun 11, 2026 · Updated 21 times
Summary
This study aimed to measure how platinum resistant ovarian cancer affects the quality of life of patients and their caregivers in Canada. Researchers planned to use questionnaires to assess symptoms, daily challenges, and work productivity. The study was terminated early, but its goal was to highlight the unmet needs and hurdles faced by this group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
PROxy Network, an initiative of PeriPharm Inc.
Montreal, Quebec, H2Y 1V3, Canada
Conditions
Explore the condition pages connected to this study.